CH545812A - - Google Patents

Info

Publication number
CH545812A
CH545812A CH402172A CH545812DA CH545812A CH 545812 A CH545812 A CH 545812A CH 402172 A CH402172 A CH 402172A CH 545812D A CH545812D A CH 545812DA CH 545812 A CH545812 A CH 545812A
Authority
CH
Switzerland
Application number
CH402172A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB825271A external-priority patent/GB1354296A/en
Application filed filed Critical
Publication of CH545812A publication Critical patent/CH545812A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/58—Nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH402172A 1971-03-30 1972-03-16 CH545812A (is")

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB825271A GB1354296A (en) 1971-03-30 1971-03-30 Nitrothiazole derivatives
GB3910671 1971-08-20

Publications (1)

Publication Number Publication Date
CH545812A true CH545812A (is") 1974-02-15

Family

ID=26242054

Family Applications (1)

Application Number Title Priority Date Filing Date
CH402172A CH545812A (is") 1971-03-30 1972-03-16

Country Status (5)

Country Link
US (1) US3870725A (is")
CH (1) CH545812A (is")
DE (1) DE2213558A1 (is")
FR (1) FR2132133B1 (is")
IT (1) IT965768B (is")

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156735A (en) * 1976-01-17 1979-05-29 Hoechst Aktiengesellschaft Thiazolidine derivatives
US4174394A (en) * 1978-03-24 1979-11-13 The Dow Chemical Company ((5-Nitro-2-thiazolyl)thio) and ((5-nitro-2-thiazolyl)sulfinyl)pyrazines
US4209522A (en) * 1978-06-28 1980-06-24 The Dow Chemical Company Antimicrobial bis(5-nitro-2-thiazolyl)thioisothiazoles and thiadiazoles
US4148899A (en) * 1978-06-28 1979-04-10 The Dow Chemical Company ((5-Nitro-2-thiazolyl)thio)polyhalogenated pyridines
US4502880A (en) * 1983-02-03 1985-03-05 E. I. Du Pont De Nemours And Company 4-Pyridinium quinazoline derivatives
US6080772A (en) * 1995-06-07 2000-06-27 Sugen, Inc. Thiazole compounds and methods of modulating signal transduction
EP0831795A2 (en) * 1995-06-07 1998-04-01 Sugen, Inc. Phosphatase inhibitors
US5798374A (en) * 1995-06-07 1998-08-25 Sugen Inc. Methods of inhibiting phosphatase activity and treatment of disorders associated therewith
SI0880508T1 (en) 1996-02-13 2003-10-31 Astrazeneca Ab Quinazoline derivatives as vegf inhibitors
JP4464466B2 (ja) 1996-03-05 2010-05-19 アストラゼネカ・ユーケイ・リミテッド ４―アニリノキナゾリン誘導体
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
IL142359A0 (en) 1998-10-08 2002-03-10 Astrazeneca Ab Quinazoline derivatives
ATE330954T1 (de) 1999-11-05 2006-07-15 Astrazeneca Ab Quinazolin-derivate als vegf-hemmer
BR0109828A (pt) 2000-04-07 2002-12-17 Astrazeneca Ab Composto, processo para a prepapação do mesmo ou de um sal deste, composição farmacêutica, uso do composto ou de um sal deste farmaceuticamente aceitável, e, método para a produção de um efeito antiangiogênico e/ou redutor da permeabilidade vascular em um animal de sangue quente em necessidade de tal tratamento
WO2002000649A1 (en) * 2000-06-28 2002-01-03 Astrazeneca Ab Substituted quinazoline derivatives and their use as inhibitors
US20110319455A1 (en) * 2010-04-19 2011-12-29 Bruce Steven Klein Antifungal Treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2744908A (en) * 1954-01-27 1956-05-08 American Cyanamid Co Process for preparing substitutedmercapto-1, 3, 4-thiadiazoles
FR1476558A (fr) * 1965-07-26 1967-04-14 Chimetron Sarl Thiazolylthiobenzimidazoles et thiazolylsulfinylbenzimidazoles

Also Published As

Publication number Publication date
IT965768B (it) 1974-02-11
DE2213558A1 (de) 1972-10-05
FR2132133A1 (is") 1972-11-17
FR2132133B1 (is") 1975-06-20
US3870725A (en) 1975-03-11

Similar Documents

Publication Publication Date Title
FR2132133B1 (is")
AU2658571A (is")
AU2691671A (is")
AU3005371A (is")
AU2684071A (is")
AU2742671A (is")
AU2726271A (is")
AU2894671A (is")
AU2941471A (is")
AU2952271A (is")
AU2836771A (is")
AU2885171A (is")
AR192311Q (is")
AU2588771A (is")
AU2654071A (is")
AU2880771A (is")
AU2724971A (is")
AU3038671A (is")
AU3025871A (is")
AU2684171A (is")
AU2963771A (is")
AU2706571A (is")
AU2669471A (is")
AU2940971A (is")
AU2938071A (is")

Legal Events

Date Code Title Description
PL Patent ceased